TMIST Breast Screening Study
TMIST is a breast screening research study comparing standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D).
Related Articles
Episode 6 SBIR Innovation Lab Podcast | Entrepreneur Spotlight – Claradele
NCI SBIR Director Michael Weingarten and Rukiyah Van Dross-Anderson, Founder and CEO of SBIR-funded Claradele Pharmaceuticals discuss the journey from postdoc to biotech startup and…
Cancer Currents: An NCI Cancer Research Blog
The Cancer Currents blog provides news and research updates from the National Cancer Institute.
Skin Cancer Prevention
Skin cancer prevention approaches include avoiding risk factors like ultraviolet radiation that comes from the sun, sun lamps, and tanning beds. Learn more about the…
Questions to Ask Your Doctor about Your Diagnosis
Suggested questions for patients to ask their doctors when they learn they have cancer and want to know what to expect next.
Putting Cancer Disparities in the Rearview Mirror
Disparities affect every aspect of the cancer experience. Tackling them will require advances and changes that go beyond the lab and doctor’s office.
Side Effects of Cancer Treatment
Side effects are problems that occur when cancer treatment affects healthy tissues or organs. Learn about side effects caused by cancer treatment. Know what signs…
Cancer HealthCast: This Unique Network Closes Research Gaps in Cancer Genomics
The effort engages cancer patients and survivors to advance research that addresses diversity and equity issues in cancer care.
Vorasidenib Is Effective against Low-Grade Gliomas
The investigational drug vorasidenib substantially slowed the growth of tumors in people with low-grade gliomas that had mutations in the IDH1 or IDH2 genes.
Food, Flora, and Function | NIH Intramural Research Program
BY MICHAEL TABASKO, THE NIH CATALYST If the saying “you are what you eat” holds true, the same might be said for our immune system,…
Two Strikes Against Mesothelioma | Center for Cancer Research
One study identified gene signatures associated with mesothelioma outcomes and responses to treatment, and a clinical trial showed that mesothelioma can be treated with adoptive…